Visage Imaging mobile diagnostic app receives FDA clearance

The FDA has granted 510(k) clearance to Visage Imaging’s Visage Ease Pro, a native iOS application that allows for mobile diagnostic interpretation of most modalities, excluding mammography.

Visage Ease Pro is a component of the Visage 7 Enterprise Imaging Platform that leverages thin-client, server-side processing technology. This server-side processing allows the app to display large studies without performance degradation even over a cellular network, according to the company. The app also can display non-DICOM images, record voice memos and upload photo attachments to studies.

Visage Imaging noted that, consistent with general FDA principles for mobile apps, mobile devices should only be used for diagnosis when no full diagnostic workstation is available, and not for mammography. The company added that interpretation with Visage Ease Pro should only be conducted on iPads and not the smaller-screened iPhone, and a user alert will be displayed with the app is used on the iPhone.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.